## Abstract It is well known that the expression level of secretory group IIA phospholipase A~2~ (sPLA~2~βIIA) is elevated in inflammatory diseases and lipopolysaccharide (LPS) upβregulates the expression of sPLA~2~βIIA in human umbilical vein endothelial cells (HUVECs). Recently, lower concentrati
Suppressive effect of ursodeoxycholic acid on type IIA phospholipase A2 expression in HepG2 cells
β Scribed by Tadashi Ikegami; Yasushi Matsuzaki; Sugano Fukushima; Junichi Shoda; Jean Luc Olivier; Bernard Bouscarel; Naomi Tanaka
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 806 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
Phospholipase A 2 IIA (PLA 2 IIA), which plays a crucial role in arachidonic acid metabolism and in inflammation, is upregulated under various pathological conditions, including in the gallbladder and gallbladder bile from patients with multiple cholesterol gallstones, in the liver and kidney of rats with cirrhosis, as well as in the colonic tissue of animals treated with a chemical carcinogen. The administration of ursodeoxycholic acid (UDCA) partially attenuated the PLA 2 IIA expression level in these different models. The aim of this study was to investigate the modulatory effect of UDCA on the PLA 2 IIA expression level at the cellular level. The HepG2 cells were selected to investigate the direct inhibitory effect of UDCA on PLA 2 IIA expression level. The proinflammatory cytokines (interleukin-6 and tumor necrosis factor β£) -induced PLA 2 IIA expression in HepG2 cells was partially inhibited by the presence of UDCA in a dose-dependent fashion. The effect of UDCA on proinflammatory cytokines-induced PLA 2 IIA expression occurred at the transcriptional level. In addition, among the bile acids tested, this inhibitory effect was UDCA-specific. In conclusion, this study supports the possible alteration of arachidonic acid metabolism and PLA 2 IIA expression level, in particular, as the protective action of UDCA in patients with chronic liver disease. (HEPATOLOGY 2005;41:896-905.) C hanges in prostaglandin levels derived from arachidonic acid have been linked to hemodynamic alterations in patients with cirrhosis. One of the rate-limiting steps in the synthesis of prostaglandins is the release of arachidonic acid from membrane phospholipids by the phospholipase A 2 (PLA 2 ) enzyme. It has been reported that a secreted type of PLA 2 , PLA 2 IIA, which
π SIMILAR VOLUMES
Effect of ursodeoxycholic acid (UDCA) treatment on the expression and function of intestinal multidrug resistance-associated protein (Mrp) 2 was examined in rats. When rats were orally administered 0.5% UDCA solution for 6 days, mRNA and protein levels of Mrp2 in the intestine were increased about t
The human undifferentiated histiocytic cell-line U937 can be induced to differentiate by incubation with 12-0-tetradecanoylphorbol-13-acetate (TPA) into macrophagelike cells. Dexamethasone reduced the prostaglandin production in TPA-differentiated U937 cells dose dependently, whereas undifferentiate
## Abstract The present study deals with the effects of Ni on the expression level of three stress proteins, namely, the cytosolic HSP72 and HSP73, and the reticulumβassociated GRP94. Experiments were carried out on βWistar'' female rats daily injected with 4 mg NiCl~2~ per kg body weight for 1, 3,
## Abstract ## Background. The protooncogenes Etsβ1 and Etsβ2 are involved in carcinogenesis of different tumors. Nimesulide, a selective cyclooxygenaseβ2 (COXβ2) inhibitor, has antiproliferative effects on tumor cells. The question arises whether nimesulide influences Etsβ1 and Etsβ2 synthesis in